|
|
|
Insider
Information: |
Sigal Elliot |
Relationship: |
Director |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
148,221 |
|
Indirect Shares
|
78,638 |
|
|
Direct
Value |
$5,965,895 |
|
|
Indirect Value
|
$5,479,085 |
|
|
Total
Shares |
226,859 |
|
|
Total
Value |
$11,444,981 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
EVP, CSO & President R... |
2013-06-03 |
148,221 |
2013-06-03 |
47,079 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2017-06-15 |
0 |
Premium* |
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2015-02-04 |
31,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-03-04 |
4 |
D |
$36.94 |
$142,773 |
D/D |
(3,865) |
115,341 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP, Global Clin & Pharm Dev |
|
2005-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
17,250 |
119,147 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,453 |
119,206 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-05-30 |
4 |
S |
$47.23 |
$6,778,497 |
D/D |
(143,521) |
132,993 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-09-20 |
4 |
D |
$27.81 |
$214,860 |
D/D |
(7,726) |
134,496 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,365 |
135,794 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-03-15 |
4 |
S |
$25.94 |
$1,233,784 |
D/D |
(47,563) |
142,222 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-06-03 |
4 |
S |
$48.18 |
$4,030,112 |
D/D |
(83,647) |
148,221 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2010-03-01 |
4 |
D |
$24.57 |
$50,098 |
D/D |
(2,039) |
151,001 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2009-12-23 |
4 |
S |
$0.00 |
$0 |
D/D |
(12,594) |
153,040 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2013-04-29 |
4 |
S |
$39.90 |
$4,188,026 |
D/D |
(104,918) |
153,493 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2008-09-19 |
4 |
D |
$21.00 |
$162,582 |
D/D |
(7,742) |
153,879 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
|
2006-03-01 |
4 |
D |
$22.94 |
$88,801 |
D/D |
(3,871) |
159,939 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2008-09-10 |
4 |
D |
$21.67 |
$83,906 |
D/D |
(3,872) |
161,621 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
|
2006-02-21 |
4 |
D |
$23.09 |
$33,850 |
D/D |
(1,466) |
163,810 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
|
2005-11-01 |
4 |
D |
$21.12 |
$81,756 |
D/D |
(3,871) |
165,276 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2008-03-02 |
4 |
D |
$22.61 |
$20,914 |
D/D |
(925) |
165,493 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2009-12-04 |
4 |
GD |
$25.14 |
$125,700 |
D/D |
5,000 |
165,634 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2008-03-01 |
4 |
D |
$22.61 |
$44,790 |
D/D |
(1,981) |
166,418 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2007-11-01 |
4 |
D |
$29.16 |
$112,908 |
D/D |
(3,872) |
168,410 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
|
2005-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
169,147 |
|
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2009-02-19 |
4/A |
D |
$20.51 |
$273,439 |
D/D |
(13,332) |
169,247 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2009-09-21 |
4 |
D |
$22.52 |
$174,350 |
D/D |
(7,742) |
170,634 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2011-05-16 |
4 |
D |
$28.90 |
$6,609,201 |
D/D |
(228,681) |
171,352 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
|
2007-09-10 |
4/A |
D |
$0.00 |
$0 |
D/D |
(3,882) |
172,271 |
0 |
- |
|
133 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|